Literature DB >> 10403175

Tissue-specific patterns of changes in 3,5,3'-triiodo-L-thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms?

H F Escobar-Morreale1, M J Obregón, F Escobar del Rey, G Morreale de Escobar.   

Abstract

We have measured 3,5,3'triiodothyronine (T3) in 12 tissues from thyroidectomized (Tx) rats infused with increasing doses of T3, and related them to their corresponding plasma levels. Young adult Wistar rats were surgically Tx. After 4 weeks, the animals were infused with placebo or T3 (0.25, 0.50, 0.75, 1.00 or 2.00 microg/100 g body weight/day). Placebo-infused intact rats served as euthyroid controls. Plasma and samples of cerebral cortex, cerebellum, brown adipose tissue (BAT), pituitary, liver, heart, lung, kidney, spleen, skeletal muscle, ovary and adrenal were obtained after 12-13 days of infusion. We determined plasma T3 and thyrotropin (TSH), and tissue T3 and thyroxine (T4), the latter being virtually undetectable. Results were compared with the relationships between tissue and plasma T3 in Tx rats on T4 infusions. Most tissues presented changes which paralleled those in plasma T3, irrespective of its source (infusion of T3, or generation from infused T4). However, at similar plasma T3 concentrations, cerebral cortex, cerebellum and BAT (containing type II 5' iodothyronine deiodinase (DII) activity), reached much lower T3 levels in the T3-infused Tx rats, than in Tx rats on T4, and required elevated plasma T3 levels for normal tissue T3. In these tissues, and in the pituitary, T3 concentrations were always lower than expected from plasma T3 levels. On the contrary, the lung and ovary of the T3-infused Tx rats contained more T3 than expected from plasma T3. Unexpectedly, both the ovary and adrenal attained higher tissue T3 concentrations in Tx rats on T3 than on T4 at comparable plasma T3 levels. In conclusion, the patterns of changes of the concentrations of T3 as a function of increasing plasma T3 are not only tissue-specific when T4 is provided, but also when circulating T3 is the only source of this iodothyronine. Further studies are needed to identify the mechanisms involved in the regulation of tissue T3 concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403175     DOI: 10.1016/s0300-9084(99)80095-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

Review 1.  The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability.

Authors:  J Köhrle
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 3.  Cardiac Thyroid Hormone Metabolism and Heart Failure.

Authors:  Rob Janssen; Alice Muller; Warner S Simonides
Journal:  Eur Thyroid J       Date:  2017-04-21

4.  Intranasal delivery of Thyroid hormones in MCT8 deficiency.

Authors:  Carmen Grijota-Martínez; Soledad Bárez-López; Eva Ausó; Samuel Refetoff; William H Frey; Ana Guadaño-Ferraz
Journal:  PLoS One       Date:  2020-07-20       Impact factor: 3.240

Review 5.  Combination Thyroid Hormone Replacement; Knowns and Unknowns.

Authors:  Peter N Taylor; Vinay Eligar; Ilaria Muller; Anna Scholz; Colin Dayan; Onyebuchi Okosieme
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-22       Impact factor: 5.555

Review 6.  Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

Authors:  Christine J Pol; Alice Muller; Warner S Simonides
Journal:  Heart Fail Rev       Date:  2010-03       Impact factor: 4.214

7.  Thyroid Hormone Availability and Action during Brain Development in Rodents.

Authors:  Soledad Bárez-López; Ana Guadaño-Ferraz
Journal:  Front Cell Neurosci       Date:  2017-08-14       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.